Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doxycycline for Exacerbation Reduction in Stable COPD
NCT02305940Phase 3Completed
- Sponsor
- Imperial College London
- Start
- Jul 2014
- Primary completion
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in chronic obstructive pulmonary disease (COPD) comparing Doxycycline with Placebo (2 arms). Primary endpoint: Rate of exacerbations at 12 months. Started Jul 2014; status: completed.
02
Drugs
doxycycline
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT02305940.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02305940.